EODData

FRA, 6NQ: BIOMED-LUBLIN WYT.SUR.

20 Aug 2026
LAST:

0.6650

CHANGE:
 0.02
OPEN:
0.6620
HIGH:
0.6650
ASK:
0.0000
VOLUME:
0
CHG(%):
2.31
PREV:
0.6500
LOW:
0.6600
BID:
0.0000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
20 Aug 260.66200.66500.66000.66500
19 Aug 260.67200.67200.65000.65000
18 Aug 260.67600.67600.67000.67000
17 Aug 260.68100.68100.67600.67600
14 Aug 260.68300.68500.68000.68000
13 Aug 260.68600.68600.67900.68200
12 Aug 260.68300.68300.67600.68100
07 Aug 260.69700.69700.69100.69200
05 Aug 260.70900.72000.70900.71300
04 Aug 260.66700.70400.66700.70400

PROFILE

Name:BIOMED-LUBLIN WYT.SUR.
About:Synthaverse S.A., a pharmaceutical company, manufactures and sells medicinal preparations, medical devices, and laboratory reagents in Poland, rest of the European Union, and internationally. It operates through BCG and Traditional segments. The company offers OnkoBCG 50 and 100, which are oncological immunotherapy products used to treat superficial and non-invasive bladder tumors; GAMMA anty-D 50 and GAMMA anty-D 150, which are human anti-rh0(d) immunoglobulin products used in the prevention of maternal-fetal conflict in terms of the D antigen with the Rh system; GAMMA anty HBs 200 medications for use in passive prophylaxis hepatitis B virus; and BCG 10 tuberculosis vaccines. It also provides Distreptaza, a gynecology and proctology reagent used in medical laboratories, in case of poisoning with pesticides and biochemical and chemical-analytical tests; LAKCID, which is a lactobacillus probiotic drug; and pseudocholinoesteraza, which is a laboratory reagent. In addition, the company engages in the contract production of injection drugs, lyophilisates of active substances in sterile sealed vials, active substances and drugs based on surface and submerged biological culture, and suppository forms of drugs. The company was formerly known as BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. and changed its name to Synthaverse S.A. in July 2023. Synthaverse S.A. was founded in 1944 and is headquartered in Lublin, Poland.
Sector:Healthcare
Industry:Biotechnology
Address:ul. Uniwersytecka 10, Lublin, Poland, 20-029
Website:https://synthaverse.com
ISIN:PLBMDLB00018
LEI:259400OWZM67D079S374

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:94.40 
PEG Ratio:0.24 
Price to Sales:0.86 
Price to Book:0.38 
Profit Margin:-0.55 
Operating Margin:-0.46 
Return on Assets:-0.04 
Return on Equity:-0.19 
Revenue:42.01M 
Shares:70.77M 
Market Cap:47.06M 

TECHNICAL INDICATORS

MA5:0.670.5%
MA10:0.682.5%
MA20:0.660.6%
MA50:0.652.5%
MA100:0.717.2%
MA200:0.8121.3%
STO9:21.43
STO14:30.38
RSI14:60.00 
WPR14:-66.67
MTM14:0.02
ROC14:0.04 
ATR:0.02 
Week High:0.693.2%
Week Low:0.652.3%
Month High:0.728.3%
Month Low:0.6221.3%
Year High:1.1674.1%
Year Low:0.5912.1%
Volatility:14.32